Effect of topical atorvastatin in seborrheic dermatitis
Phase 3
Recruiting
- Conditions
- seborrheic dermatitis.Other seborrhoeic dermatitis
- Registration Number
- IRCT2017070922965N11
- Lead Sponsor
- vice chancellor for research,Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
inclusion criteria:Patients with seborrheic dermatitis in the scalp and face with clinical diagnosis?Lack of treatment with topical or systemic corticosteroids?Methyl dopa? Chlorpromazine?Topical or systemic acne medications from a month before referral?Failure to develop a systemic disorder, such as Parkinson's disease, AIDS, mood disorders.
exclusion criteria:Report any allergy to the drug, such as Contact dermatitis?Dissatisfaction with drug use and collaborative study?Lack of referral for follow up and observation of the therapeutic efficacy of the drug?Having a very severe type of disease(Itching score greater than 7)?Pregnancy and lactation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seborrheic dermatitis. Timepoint: 2 and 4 weeks following of treatment and4 weeks after the end of treatment. Method of measurement: Koca scoring system.
- Secondary Outcome Measures
Name Time Method